1-Isomangostin

CAS No. 19275-44-6

1-Isomangostin( —— )

Catalog No. M29257 CAS No. 19275-44-6

1-Isomangostin has cytotoxic and anticomplementary activities.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 393 Get Quote
10MG 581 Get Quote
25MG 888 Get Quote
50MG 1242 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    1-Isomangostin
  • Note
    Research use only, not for human use.
  • Brief Description
    1-Isomangostin has cytotoxic and anticomplementary activities.
  • Description
    1-Isomangostin has cytotoxic and anticomplementary activities.(In Vitro):Garcimangostanol (1), 8-deoxygartanin (2), 1-Isomangostin (3), and garcinone C (4) exhibited either significant o r moderate cytotoxicity against MCF-7, A549, Hep-G2 and CNEhuman cancer cell lines in vitro with IC50 values from 4.0 +/- 0.3 to 23.6+/- 1.5 microM by MTT colorimetric assay.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    NF-κB
  • Recptor
    NF-κB
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    19275-44-6
  • Formula Weight
    410.5
  • Molecular Formula
    C24H26O6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1c(O)cc2oc3cc(O)c4CCC(C)(C)Oc4c3c(=O)c2c1CC=C(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • NF-κB-IN-1

    NF-κB-IN-1 is a potent NF-κB signaling pathway inhibitor. It is a 4-arylidene crucumin analogue. NF-κB-IN-1 directly inhibits IKK to block NF-κB activation.

  • L6H21

    L6H21 is an MD-2 inhibitor that can be used to study cognitive impairment and brain damage.

  • Withaferin A

    Withaferin A is a steroid lactone that displays anti-inflammatory, antitumor and antiangiogenic activity, potently inhibits NF-κB activation.